the CPMP on Part II of the dossier of certain applications submitted under the centralised procedure and on manufacture and control of medicinal products derived from blood and plasma, and of immunological products. “ Biotechnology” guidelines adopted or released for consultation by the CPMP in 1996 are outlined below.